Furthermore, ET-1 and the cGMP/NT-proBNP ratio predicted future 6MWD in a larger cohort of patients with pulmonary vascular disease that included patients with CTEPH, as well as PAH patients with concomitant heart or lung disease. The gene discussed is NPPB; the disease is lung disorder.